A special commitment to innovation
Through our deeply ingrained commitment to innovative R&D, Nexus Pharmaceuticals identifies those off-patent and unique molecules that can be developed, improved upon and commercialized so as to advance industry standards and deliver on the critical medical need.
We seek out difficult-to-formulate molecules with significant medical need
We innovate and improve the formulations to advance industry practice
We maintain the highest standards to deliver FDA-approved, life-saving drugs
A special attention to quality
Through our partnerships with leading US-based industry suppliers and manufacturers, privately-held Nexus Pharmaceuticals can ensure consistent, dependable access to the highest-quality products. Our steadfast record of delivery ensures that our critical-need drugs are always available when and where they’re needed most.
Isoproterenol HCL Injection
Levetiracetam in Sodium Chloride Injection
(3 concentrations)
Arsenic Trioxide Injection
News
Nexus Pharmaceuticals sets month for $100M plant opening, preps drug for treating Covid patients
Nexus Pharmaceuticals Inc. plans to complete its nearly $100 million Pleasant Prairie sterile injectables plant in April 2021 and a company executive said it will help address the United States’ reliance on foreign pharmaceutical suppliers magnified by the Covid-19 pandemic.
Nexus Pharmaceuticals Announces Diversity Certification
Nexus Pharmaceuticals is pleased to announce their continuous certification as a Minority Business Enterprise (MBE) and a Women’s Business Enterprise (WBE).
At Nexus Pharmaceuticals, improving the lives of patients and the people who care for them are at the heart of what we do every day.
Yannick Vidinhouede,
Supply Chain Analyst
Find out what we’re about
Discover more and let’s start a conversation
Lincolnshire, IL 60069 United States
